doi: 10.1042/cs057433s.
SK&F 92657, a novel antihypertensive acting by precapillary vasodilatation and beta-adrenoreceptor blockade
- PMID: 44235
- DOI: 10.1042/cs057433s
Item in Clipboard
SK&F 92657, a novel antihypertensive acting by precapillary vasodilatation and beta-adrenoreceptor blockade
Clin Sci (Lond).
1979 Dec.
Abstract
1. The properties of a new antihypertensive agent, SK&F 92657, DL-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine, have been studied. 2. The compound caused a sustained fall in blood pressure in several species as a result of precapillary vasodilatation, particularly in the renal and coronary vasculatures. 3. The beta-adrenoreceptor-blocking actions of SK&F 92657 prevent reflex cadiac stimulation.
Similar articles
-
Hemodynamic profile of a new antihypertensive agent D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657).J Cardiovasc Pharmacol. 1981 Mar-Apr;3(2):337-54. doi: 10.1097/00005344-198103000-00012. J Cardiovasc Pharmacol. 1981. PMID: 6166805
-
Studies on the autonomic nervous system with SK&F 92657, a new antihypertensive agent causing direct arterial vasodilatation and beta-adrenoceptor blockade.J Cardiovasc Pharmacol. 1981 Mar-Apr;3(2):355-68. doi: 10.1097/00005344-198103000-00013. J Cardiovasc Pharmacol. 1981. PMID: 6166806
-
SK & F 95018, a vasodilator/beta-adrenoceptor antagonist.Arch Int Pharmacodyn Ther. 1987 Oct;289(2):251-66. Arch Int Pharmacodyn Ther. 1987. PMID: 2892473
-
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4. Br J Clin Pharmacol. 1976. PMID: 10948 Review.
-
Beta-adrenergic receptors and responses in the heart.Postgrad Med J. 1981;57 Suppl 1:62-70. Postgrad Med J. 1981. PMID: 6272252 Review.
Cited by
-
Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study.Eur J Clin Pharmacol. 1983;25(2):179-86. doi: 10.1007/BF00543788. Eur J Clin Pharmacol. 1983. PMID: 6138257
-
Cardiovascular effects in man of intravenous prizidilol hydrochloride (SK&F 92657); a new antihypertensive agent.Br J Clin Pharmacol. 1981 Oct;12(4):567-72. doi: 10.1111/j.1365-2125.1981.tb01266.x. Br J Clin Pharmacol. 1981. PMID: 7295490 Free PMC article.
-
Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.Br J Clin Pharmacol. 1981 Oct;12(4):573-8. doi: 10.1111/j.1365-2125.1981.tb01267.x. Br J Clin Pharmacol. 1981. PMID: 6117309 Free PMC article. Clinical Trial.
-
Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension.Eur J Clin Pharmacol. 1982;23(5):411-5. doi: 10.1007/BF00605990. Eur J Clin Pharmacol. 1982. PMID: 6129980
-
An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.Br J Clin Pharmacol. 1982 May;13(5):711-6. doi: 10.1111/j.1365-2125.1982.tb01441.x. Br J Clin Pharmacol. 1982. PMID: 6123343 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
